Vidič Maša, Bartenjev Igor
Department of Dermatology and Venereology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Department of Dermatology and Venereology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Acta Dermatovenerol Alp Pannonica Adriat. 2018 Sep;27(3):165-167.
Among several skin fillers developed in recent decades, hyaluronic acid (HA) fillers have become the material of choice. They are safe, long-lasting, not immunogenic, and cost effective, and they can be removed with hyaluronidase. Unfortunately, early and delayed complications can also occur following HA filler injection. Here we report the case of a hyaluronic filler-related complication in a 50-year-old female patient. The locations affected were the forehead, glabella, and nose. Three days after HA filler application in the upper lip, glabellar region, and nasal root, with no immediate diverse reaction at the time of application, an erythematous, livedoid rash with a well-defined border occurred at the site of the injection in the glabellar region, including the area from the nasal root to the scalp and left upper eyelid. Because an infection or allergy was suspected, she was first given an antibiotic for 6 days p.o. and later also a corticosteroid systemically with good results. Two years later (in 2017) the patient decided to repeat the treatment with HA injections in the glabellar region and experienced no adverse reactions.
在近几十年开发的几种皮肤填充剂中,透明质酸(HA)填充剂已成为首选材料。它们安全、持久、无免疫原性且具有成本效益,并且可以用透明质酸酶去除。不幸的是,注射HA填充剂后也可能出现早期和延迟并发症。在此,我们报告一例50岁女性患者发生的与透明质酸填充剂相关的并发症。受累部位为前额、眉间和鼻子。在对上唇、眉间区域和鼻根注射HA填充剂三天后,注射时未出现即时的不同反应,眉间区域的注射部位出现了边界清晰的红斑性、类紫癜样皮疹,包括从鼻根到头皮和左上眼睑的区域。由于怀疑有感染或过敏,她首先口服抗生素6天,后来还全身使用了皮质类固醇,效果良好。两年后(2017年),患者决定在眉间区域重复注射HA进行治疗,未出现不良反应。